Supplementary Figure 3 from Preclinical and Early Clinical Evaluation of the Oral AKT Inhibitor, MK-2206, for the Treatment of Acute Myelogenous Leukemia

Authors :: Hagop M. Kantarjian
Elihu H. Estey
L. Austin Doyle
Steven M. Kornblau
Keith A. Baggerly
Wenbin Liu
Michael Andreeff
Jan A. Burger
LaKiesha Debose
Hongbo Lu
Jennie B. Feliu
Peter P. Ruvolo
Tapan M. Kadia
Xuelin Huang
Gautam Borthakur
Zhihong Zeng
Elias J. Jabbour
Stefan H. Faderl
Roland B. Walter
Marina Y. Konopleva
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file - 50KB, Correlation between RPPA and immunoblotting in samples from the patients treated on MK-2206 trial.

Full Text Access

Tools